(RTTNews) – In the healthcare sector, only 1 company made its stock market debut in January.
Now, let's take a look at the U.S. biotech IPO calendar of this week
Harpoon Therapeutics Inc.
Harpoon Therapeutics, Inc. is a clinical-stage an immuno-oncology company, and its proprietary antibody-based drug discovery platform is called TriTAC, which offers a new way to unleash the target cell-killing properties of a patient's own immune system.
The company has planned to list its IPO on the Nasdaq Global Select Market, under the symbol “HARP”, on February 4.